Desire for parenthood and reproductive health knowledge in adolescents and young adults with sickle cell disease and their caregivers

被引:25
作者
Nahata, Leena [1 ,2 ]
Caltabellotta, Nicole M. [2 ]
Ball, Kyle [3 ]
O'Brien, Sarah H. [3 ,4 ]
Creary, Susan E. [3 ,4 ]
机构
[1] Ohio State Univ, Coll Med, Nationwide Childrens Hosp, Div Endocrinol,Dept Pediat, Columbus, OH 43210 USA
[2] Nationwide Childrens Hosp, Res Inst, Ctr Biobehav Hlth, 700 Childrens Dr, Columbus, OH 43205 USA
[3] Nationwide Childrens Hosp, Res Inst, Ctr Innovat Pediat Practice, Columbus, OH USA
[4] Nationwide Childrens Hosp, Dept Hematol & Oncol, Columbus, OH USA
基金
美国国家卫生研究院;
关键词
adolescents; hydroxyurea; infertility; parenthood; reproductive health; sickle cell disease; FERTILITY PRESERVATION; CANCER SURVIVORS; CHILDHOOD-CANCER; HYDROXYUREA; OUTCOMES; ANEMIA; IMPACT; MALES; INTENTIONS; PREGNANCY;
D O I
10.1002/pbc.26829
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/objectiveSickle cell disease (SCD) and hydroxyurea have implications for fertility and reproductive health. The goal of this study was to examine desire for parenthood and reproductive health knowledge among a cohort of adolescent and young adult (AYA) with SCD receiving hydroxyurea and their caregivers at a large pediatric academic center. MethodsPatients with SCD were approached from September 2016 to July 2017 if they were: (1) 12-20 years old, (2) prescribed hydroxyurea for at least 6 months, (3) proficient in English, and (4) accompanied by a caregiver who was proficient in English and willing to participate. Participants self-reported sociodemographic characteristics and completed surveys to assess their/their child's desire for parenthood and other life goals, and reproductive health knowledge. ResultsEighteen patient-caregiver dyads completed the study (78.3% of those eligible); 61.1% indicated that they wanted to have future biological children. Few participants reported receiving information about fertility (16.7% of AYA and 27.8% of caregivers) or birth control (11.1% of AYA and 22.2% of caregivers) from their/their child's health care provider, and the majority had received no information on these topics. Less than half of participants reported that SCD (22.2% of AYA and 50.0% of caregivers) or hydroxyurea (11.1% of AYA and 27.8% of parents) could potentially impair fertility. ConclusionsBiological parenthood was important to this cohort yet fertility and reproductive health knowledge was low, suggesting that clinicians should prioritize conversations about infertility risk and birth control options with AYA with SCD on hydroxyurea and their caregivers. More research is needed to identify optimal approaches to these discussions.
引用
收藏
页数:6
相关论文
共 29 条
  • [1] Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion
    Amato, Paula
    Brzyski, Robert
    Benward, Jean
    Stein, Andrea
    Steinbock, Bonnie
    Wilder, Bruce
    Reindollar, Richard
    Francis, Leslie
    Zoloth, Laurie
    McCullough, Laurence
    Gates, Elena
    Robertson, John
    Daar, Judith
    Fisseha, Senait
    Ralston, Steven
    Sauer, Mark
    Spillman, Monique
    Rebar, Robert
    Tipton, Sean
    [J]. FERTILITY AND STERILITY, 2013, 100 (05) : 1224 - 1231
  • [2] Exposure to Hydroxyurea and Pregnancy Outcomes in Patients With Sickle Cell Anemia
    Ballas, Samir K.
    McCarthy, William F.
    Guo, Nan
    DeCastro, Laura
    Bellevue, Rita
    Barton, Bruce A.
    Waclawiw, Myron A.
    [J]. JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2009, 101 (10) : 1046 - 1051
  • [3] Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males
    Berthaut, Isabelle
    Guignedoux, Geoffroy
    Kirsch-Noir, Frederique
    de Larouziere, Vanina
    Ravel, Celia
    Bachir, Dora
    Galacteros, Frederic
    Ancel, Pierre-Yves
    Kunstmann, Jean-Marie
    Levy, Laurence
    Jouannet, Pierre
    Girot, Robert
    Mandelbaum, Jacqueline
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (07): : 988 - 993
  • [4] Attitudes regarding fertility preservation in female adolescent cancer patients
    Burns, Karen C.
    Boudreau, Christian
    Panepinto, Julie A.
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2006, 28 (06) : 350 - 354
  • [5] The psychosocial impact of interrupted childbearing in long-term female cancer survivors
    Canada, Andrea L.
    Schover, Leslie R.
    [J]. PSYCHO-ONCOLOGY, 2012, 21 (02) : 134 - 143
  • [6] Committee on Adolescence, 2014, PEDIATRICS, V134, pe1257
  • [7] Hydroxyurea use in Children with Sickle Cell Disease: Do Severely Affected Patients Use It and Does It Impact Hospitalization Outcomes?
    Creary, Susan E.
    Chisolm, Deena J.
    Koch, Terah L.
    Zigmont, Victoria A.
    Lu, Bo
    O'Brien, Sarah H.
    [J]. PEDIATRIC BLOOD & CANCER, 2016, 63 (05) : 844 - 847
  • [8] Shared Decision Making for Hydroxyurea Treatment Initiation in Children With Sickle Cell Anemia
    Crosby, Lori E.
    Shook, Lisa M.
    Ware, Russell E.
    Brinkman, William B.
    [J]. PEDIATRIC BLOOD & CANCER, 2015, 62 (02) : 184 - 185
  • [9] The role of knowledge and perceived susceptibility in intentions to optimize fertility: findings from the International Fertility Decision-Making Study (IFDMS)
    Fulford, B.
    Bunting, L.
    Tsibulsky, I.
    Boivin, J.
    [J]. HUMAN REPRODUCTION, 2013, 28 (12) : 3253 - 3262
  • [10] Nonmalignant Diseases and Treatments Associated with Primary Ovarian Failure: An Expanded Role for Fertility Preservation
    Hirshfeld-Cytron, Jennifer
    Gracia, Clarisa
    Woodruff, Teresa K.
    [J]. JOURNAL OF WOMENS HEALTH, 2011, 20 (10) : 1467 - 1477